Cited by 123Intracerebral and Subarachnoid Hemorrhage ResearchAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

APOE and cerebral amyloid angiopathy in community-dwelling older persons

Open access
Yu, Lei, Boyle, Patricia A., Nag, Sukriti, Leurgans, Sue, Buchman, Aron S., Wilson, Robert S., Arvanitakis, Zoe, Farfel, Jose M. +3 more·2015·Neurobiology of Aging

Abstract

Both cerebral amyloid angiopathy and Alzheimer's disease pathology involve abnormal β-amyloid processing. We aim to elucidate the relationship of the apolipoprotein E (APOE) genotypes with amyloid angiopathy in the presence of variable amounts of Alzheimer's pathology. Data came from 1062 autopsied subjects from 2 community-based studies of aging. Common neuropathologies including Alzheimer's disease and amyloid angiopathy were assessed using uniform methods. APOE was genotyped by sequencing the 2 polymorphisms in codons 112 and 158 of exon 4. We examined the associations of APOE with amyloid angiopathy using ordinal logistic regression analyses, controlling for demographics and subsequently Alzheimer's and other common pathologies. Moderate to severe amyloid angiopathy was identified in 35.2% (n = 374) of the subjects; 15.3% (n = 162) of the subjects were APOE ε2 carriers; and 26.1% (n = 277) ε4 carriers. Adjusting for demographics, the presence of ε4 allele, but not ε2, was associated with more severe amyloid angiopathy. After further adjustment for Alzheimer's pathology, both ε2 (odds ratio 1.707, 95% confidence interval 1.236-2.358, p = 0.001) and ε4 (odds ratio 2.284, 95% confidence interval 1.730-3.014, p < 0.001) were independently associated with amyloid angiopathy. The results were confirmed by path analysis. Furthermore, APOE ε4 carriers, but not ε2 carriers, were more likely to have capillary amyloid angiopathy. Accounting for capillary involvement did not alter the APOE associations with amyloid angiopathy. We conclude that both APOE ε2 and ε4 alleles are associated with more severe cerebral amyloid angiopathy, and the direct effect of ε2 is masked by the allele's negative association with comorbid Alzheimer's pathology. APOE ε4, but not ε2, is associated with capillary amyloid angiopathy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2015.08.008

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A subtype of capillary cerebral amyloid angiopathy has been associated with APOEε4 carriage.

    “Of note, although CAA typically affects leptomeningeal and cortical medium- and small-sized arteries, a subtype of capillary CAA has been associated with APOEε4 carriage51,52.”

    From Multifaceted roles of APOE in Alzheimer disease (2024) · cites this paper as [51]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 41

  1. Alonzo NC Hyman BT Rebeck GW Greenberg SM 1998 Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels Journal of neuropathology and experimental neurology 57 4 353 9 9600229
  2. Arold S Sullivan P Bilousova T Teng E Miller CA Poon WW Vinters HV Cornwell LB Saing T Cole GM Gylys KH 2012 Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer’s disease and apoE TR mouse cortex Acta neuropathologica 123 1 39 52 10.1007/s00401-011-0892-1 22020632 PMC3404604 · DOI
  3. Arvanitakis Z Leurgans SE Barnes LL Bennett DA Schneider JA 2011a Microinfarct pathology, dementia, and cognitive systems Stroke; a journal of cerebral circulation 42 3 722 7 10.1161/strokeaha.110.595082 PMC3042494 21212395 · DOI · Paper page
  4. Arvanitakis Z Leurgans SE Wang Z Wilson RS Bennett DA Schneider JA 2011b Cerebral amyloid angiopathy pathology and cognitive domains in older persons Annals of neurology 69 2 320 7 10.1002/ana.22112 21387377 PMC3228518 · DOI · Paper page
  5. Auriel E Greenberg SM 2012 The pathophysiology and clinical presentation of cerebral amyloid angiopathy Current atherosclerosis reports 14 4 343 50 10.1007/s11883-012-0254-z 22565298 · DOI
  6. Bennett DA Schneider JA Arvanitakis Z Wilson RS 2012a Overview and findings from the religious orders study Current Alzheimer research 9 6 628 22471860 PMC3409291
  7. Bennett DA Schneider JA Buchman AS Barnes LL Boyle PA Wilson RS 2012b Overview and findings from the Rush Memory and Aging Project Current Alzheimer research 9 6 646 22471867 PMC3439198
  8. Bennett DA Schneider JA Tang Y Arnold SE Wilson RS 2006b The effect of social networks on the relation between Alzheimer’s disease pathology and level of cognitive function in old people: a longitudinal cohort study The Lancet Neurology 5 5 406 12 10.1016/s1474-4422(06)70417-3 16632311 · DOI · Paper page
  9. Biffi A Anderson CD Jagiella JM Schmidt H Kissela B Hansen BM Jimenez-Conde J Pires CR Ayres AM Schwab K Cortellini L Pera J Urbanik A Romero JM Rost NS Goldstein JN Viswanathan A Pichler A Enzinger C Rabionet R Norrving B Tirschwell DL Selim M Brown DL Silliman SL Worrall BB Meschia JF Kidwell CS Broderick JP Greenberg SM Roquer J Lindgren A Slowik A Schmidt R Woo D Rosand J 2011 APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study The Lancet Neurology 10 8 702 9 10.1016/s1474-4422(11)70148-x 21741316 PMC3153411 · DOI
  10. Biffi A Sonni A Anderson CD Kissela B Jagiella JM Schmidt H Jimenez-Conde J Hansen BM Fernandez-Cadenas I Cortellini L Ayres A Schwab K Juchniewicz K Urbanik A Rost NS Viswanathan A Seifert-Held T Stoegerer EM Tomas M Rabionet R Estivill X Brown DL Silliman SL Selim M Worrall BB Meschia JF Montaner J Lindgren A Roquer J Schmidt R Greenberg SM Slowik A Broderick JP Woo D Rosand J 2010 Variants at APOE influence risk of deep and lobar intracerebral hemorrhage Annals of neurology 68 6 934 43 10.1002/ana.22134 21061402 PMC3058266 · DOI
  11. Boyle PA Buchman AS Wilson RS Kelly JF Bennett DA 2010 The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons Neuroepidemiology 34 1 43 9 10.1159/000256662 19907191 PMC2857623 · DOI
  12. Brouwers HB Biffi A McNamara KA Ayres AM Valant V Schwab K Romero JM Viswanathan A Greenberg SM Rosand J Goldstein JN 2012 Apolipoprotein E genotype is associated with CT angiography spot sign in lobar intracerebral hemorrhage Stroke; a journal of cerebral circulation 43 8 2120 5 10.1161/strokeaha.112.659094 PMC3426364 22621984 · DOI
  13. Burgermeister P Calhoun ME Winkler DT Jucker M 2000 Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models Annals of the New York Academy of Sciences 903 307 16 10818520
  14. Cadavid D Mena H Koeller K Frommelt RA 2000 Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies Journal of neuropathology and experimental neurology 59 9 768 73 11005257
  15. Calhoun ME Burgermeister P Phinney AL Stalder M Tolnay M Wiederhold KH Abramowski D Sturchler-Pierrat C Sommer B Staufenbiel M Jucker M 1999 Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid Proceedings of the National Academy of Sciences of the United States of America 96 24 14088 93 10570203 PMC24195
  16. Carare RO Bernardes-Silva M Newman TA Page AM Nicoll JA Perry VH Weller RO 2008 Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology Neuropathology and applied neurobiology 34 2 131 44 10.1111/j.1365-2990.2007.00926.x 18208483 · DOI · Paper page
  17. Deane R Du Yan S Submamaryan RK LaRue B Jovanovic S Hogg E Welch D Manness L Lin C Yu J Zhu H Ghiso J Frangione B Stern A Schmidt AM Armstrong DL Arnold B Liliensiek B Nawroth P Hofman F Kindy M Stern D Zlokovic B 2003 RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain Nature medicine 9 7 907 13 10.1038/nm890 12808450 · DOI · Paper page
  18. Deramecourt V Slade JY Oakley AE Perry RH Ince PG Maurage CA Kalaria RN 2012 Staging and natural history of cerebrovascular pathology in dementia Neurology 78 14 1043 50 10.1212/WNL.0b013e31824e8e7f 22377814 PMC3317531 · DOI · Paper page
  19. Devan WJ Falcone GJ Anderson CD Jagiella JM Schmidt H Hansen BM Jimenez-Conde J Giralt-Steinhauer E Cuadrado-Godia E Soriano C Ayres AM Schwab K Kassis SB Valant V Pera J Urbanik A Viswanathan A Rost NS Goldstein JN Freudenberger P Stogerer EM Norrving B Tirschwell DL Selim M Brown DL Silliman SL Worrall BB Meschia JF Kidwell CS Montaner J Fernandez-Cadenas I Delgado P Greenberg SM Roquer J Lindgren A Slowik A Schmidt R Woo D Rosand J Biffi A 2013 Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage Stroke; a journal of cerebral circulation 44 6 1578 83 10.1161/strokeaha.111.000089 PMC3684199 23559261 · DOI
  20. Greenberg SM Rebeck GW Vonsattel JP Gomez-Isla T Hyman BT 1995 Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy Annals of neurology 38 2 254 9 10.1002/ana.410380219 7654074 · DOI
  21. Greenberg SM Vonsattel JP 1997 Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy Stroke; a journal of cerebral circulation 28 7 1418 22 9227694
  22. Herzig MC Van Nostrand WE Jucker M 2006 Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models Brain pathology (Zurich, Switzerland) 16 1 40 54 PMC8095938 16612981
  23. Holtzman DM Bales KR Tenkova T Fagan AM Parsadanian M Sartorius LJ Mackey B Olney J McKeel D Wozniak D Paul SM 2000 Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer’s disease Proceedings of the National Academy of Sciences of the United States of America 97 6 2892 7 10.1073/pnas.050004797 10694577 PMC16026 · DOI · Paper page
  24. Love S Chalmers K Ince P Esiri M Attems J Jellinger K Yamada M McCarron M Minett T Matthews F Greenberg S Mann D Kehoe PG 2014 Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue American journal of neurodegenerative disease 3 1 19 32 24754000 PMC3986608
  25. Love S Miners S Palmer J Chalmers K Kehoe P 2009 Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy Frontiers in bioscience (Landmark edition) 14 4778 92 19273389
  26. McCarron MO Nicoll JA 2000 Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage Annals of the New York Academy of Sciences 903 176 9 10818505
  27. Obici L Demarchi A de Rosa G Bellotti V Marciano S Donadei S Arbustini E Palladini G Diegoli M Genovese E Ferrari G Coverlizza S Merlini G 2005 A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy Annals of neurology 58 4 639 44 10.1002/ana.20571 16178030 · DOI
  28. Premkumar DR Cohen DL Hedera P Friedland RP Kalaria RN 1996 Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer’s disease The American journal of pathology 148 6 2083 95 8669492 PMC1861657
  29. Rannikmae K Kalaria RN Greenberg SM Chui HC Schmitt FA Samarasekera N Al-Shahi Salman R Sudlow CL 2014 APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis Journal of neurology, neurosurgery, and psychiatry 85 3 300 5 10.1136/jnnp-2013-306485 PMC4018226 24163429 · DOI
  30. Roses AD Saunders AM 1994 APOE is a major susceptibility gene for Alzheimer’s disease Current opinion in biotechnology 5 6 663 7 7765750
  31. Samarasekera N Smith C Al-Shahi Salman R 2012 The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis Journal of neurology, neurosurgery, and psychiatry 83 3 275 81 10.1136/jnnp-2011-300371 22056966 · DOI
  32. Schneider JA Arvanitakis Z Yu L Boyle PA Leurgans SE Bennett DA 2012 Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies Brain: a journal of neurology 135 Pt 10 3005 14 10.1093/brain/aws234 23065790 PMC3470712 · DOI · Paper page
  33. Schneider JA Bienias JL Wilson RS Berry-Kravis E Evans DA Bennett DA 2005 The apolipoprotein E epsilon4 allele increases the odds of chronic cerebral infarction [corrected] detected at autopsy in older persons Stroke; a journal of cerebral circulation 36 5 954 9 10.1161/01.STR.0000160747.27470.2a 15774818 · DOI
  34. Thal DR Ghebremedhin E Rub U Yamaguchi H Del Tredici K Braak H 2002 Two types of sporadic cerebral amyloid angiopathy Journal of neuropathology and experimental neurology 61 3 282 93 11895043
  35. Tsuang D Leverenz JB Lopez OL Hamilton RL Bennett DA Schneider JA Buchman AS Larson EB Crane PK Kaye JA Kramer P Woltjer R Trojanowski JQ Weintraub D Chen-Plotkin AS Irwin DJ Rick J Schellenberg GD Watson GS Kukull W Nelson PT Jicha GA Neltner JH Galasko D Masliah E Quinn JF Chung KA Yearout D Mata IF Wan JY Edwards KL Montine TJ Zabetian CP 2013 APOE epsilon4 increases risk for dementia in pure synucleinopathies JAMA neurology 70 2 223 8 10.1001/jamaneurol.2013.600 23407718 PMC3580799 · DOI · Paper page
  36. Tzourio C Arima H Harrap S Anderson C Godin O Woodward M Neal B Bousser MG Chalmers J Cambien F MacMahon S 2008 APOE genotype, ethnicity, and the risk of cerebral hemorrhage Neurology 70 16 1322 8 10.1212/01.wnl.0000308819.43401.87 18256366 · DOI
  37. Valant V Keenan BT Anderson CD Shulman JM Devan WJ Ayres AM Schwab K Goldstein JN Viswanathan A Greenberg SM Bennett DA De Jager PL Rosand J Biffi A 2012 TOMM40 in Cerebral Amyloid Angiopathy Related Intracerebral Hemorrhage: Comparative Genetic Analysis with Alzheimer’s Disease Translational stroke research 3 Suppl 1 102 12 10.1007/s12975-012-0161-1 24323865 PMC4054941 · DOI
  38. Van Dorpe J Smeijers L Dewachter I Nuyens D Spittaels K Van Den Haute C Mercken M Moechars D Laenen I Kuiperi C Bruynseels K Tesseur I Loos R Vanderstichele H Checler F Sciot R Van Leuven F 2000 Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons The American journal of pathology 157 4 1283 98 10.1016/S0002-9440(10)64644-5 11021833 PMC1850171 · DOI
  39. Weller RO Massey A Newman TA Hutchings M Kuo YM Roher AE 1998 Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer’s disease The American journal of pathology 153 3 725 33 9736023 PMC1853019
  40. Weller RO Subash M Preston SD Mazanti I Carare RO 2008 Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer’s disease Brain pathology (Zurich, Switzerland) 18 2 253 66 10.1111/j.1750-3639.2008.00133.x PMC8095597 18363936 · DOI
  41. Yu L Boyle PA Leurgans S Schneider JA Bennett DA 2014 Disentangling the effects of age and APOE on neuropathology and late life cognitive decline Neurobiology of aging 35 4 819 26 10.1016/j.neurobiolaging.2013.10.074 24199961 PMC3882071 · DOI · Paper page

Cited by

Sorted by citations

Authors
Yu, L., Boyle, P. A., Nag, S., Leurgans, S., Buchman, A. S., Wilson, R. S., Arvanitakis, Z., Farfel, J. M., De Jager, P. L., Bennett, D. A., & Schneider, J. A.
Affiliations
Rush University Medical Center (US)
Corresponding author
Yu, Lei
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2015-11
Volume
36
Issue
11
Pages
2946-2953
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2096355806
Cited by
123
References
8
Citations by year
2026: 14 · 2025: 17 · 2024: 15 · 2023: 11 · 2022: 10 · 2021: 13 · 2020: 10 · 2019: 12 · 2018: 10 · 2017: 5 · 2016: 5 · 2015: 1
FWCI
4.94
Type
journal article
Language
en
Open access
Locations
  • Neurobiology of Aging (publishedVersion)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Aging (P30AG10161, R01AG17917, R01AG15819, R01AG043379, R01AG34374, R01NS084965)
  • Illinois Department of Public Health
Topics
  • Health Sciences › Medicine › Neurology › Intracerebral and Subarachnoid Hemorrhage Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
apolipoprotein E, APOE ε4, APOE ε2, cerebral amyloid angiopathy, Alzheimer's disease pathology, genetic risk factors, older adults, neuropathology
MeSH terms
Aged, Aged, 80 and over, Alleles, Alzheimer Disease, Female, Genotype, Heterozygote, Humans, Male, Severity of Illness Index, Logistic Models, Cerebral Amyloid Angiopathy, Apolipoprotein E4, Genetic Association Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review